PZ
Investo's verdict, shared with you
No fair value published
The derivation ran and was refused by our own plausibility checks. We publish no number rather than a plausible-looking one.
Why · 2 checks
Our valuation methods disagree
The earnings-based and book-based readings of this company differ by more than 2.5×. That spread is real information, but averaging it would manufacture a number no method actually produced.
Implied book multiple is far from the peer group
At the computed value this company would trade at a P/B a long way from its sector median. Either the book-value input or the peer anchor is unreliable.
What we would need
- Earnings and book value drawn from the same set of accounts, so the two legs can be reconciled.
- A verified book value per share, or a peer group with enough clean constituents.
Show what the engine computed
Method spread · 6.01× between the highest and lowest valuation leg.
Methods disagree · The valuation legs disagree by 6.01x (Blended P/E band ₦185.72 vs Blended P/B band ₦30.88). No point estimate is defensible until the inputs are reconciled.
Implied P/B off peers · Implied P/B at base 25.4x is 4.51x the sector median 5.63x.
PZ Cussons Nigeria (PZ) has staged a dramatic operational recovery in FY2026, delivering 22% revenue growth to ₦260.5bn and a 307% surge in operating profit, translating to EPS of ₦11.80 versus a loss year in FY2024, which signals genuine business rehabilitation rather than a one-off. At the current price of ₦80, the stock trades at a deeply compressed 6.78x trailing P/E against a sector median of 15.74x, presenting a meaningful valuation gap if earnings quality proves durable. The committee score flags positive signals on value, quality, and risk, though neutral momentum and absent dividend data temper the near-term conviction.
Verdict published 2026-08-15 · fundamentals through FY2026 · reviewed as the data changes
Source: NGX live market data · Investo intelligence. Educational only — not financial advice.